Embecta said its patch pump would require additions to be commercially competitive, and plans to use the funds saved to pay ...

BTIG analyst Marie Thibault upgraded Embecta Corporation (EMBC – Research Report) to a Buy today and set a price target of $26.00. The ...

Rockefeller Capital Management L.P. lifted its holdings in shares of Embecta Corp. (NASDAQ:EMBC – Free Report) by 3.7% during ...

Embecta (Nasdaq:EMBC) filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees.

Charles Schwab Investment Management Inc. lowered its stake in Embecta Corp. (NASDAQ:EMBC – Free Report) by 17.1% in the ...

Embecta Corp.'s Q4 results showed significant net income and EPS growth. Embecta also announced a restructuring plan. See why ...

Embecta Corp. has notified the state that it intends to terminate 118 employees that work out of its facility at 200 Bulfinch ...

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

On Tuesday, Embecta Corp (NASDAQ:EMBC) posted the fourth-quarter adjusted EPS of 45 cents, beating the consensus of 36 cents ...

Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our ...

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that ...

After adding nearly 30% in the previous session following its better-than-expected Q4 results for FY24, Embecta (NASDAQ:EMBC) ...